Helsinn Group operates through a unique business model of Integrated Licensing, focused on the in-licensing of Novel Chemical Entities (NCE) from R&D partners, and the out-licensing of its entire pipeline of products to a wide network of commercial partners. We have established a network covering approximately 190 countries, bringing together the brightest minds and motivated organizations.
For over 40 years we have achieved success with our partners, who share our values and ambition to improve the everyday lives of patients. We have established a network covering more than 90 countries, bringing together the brightest minds and motivated organizations. We have maintained our 360-degree approach to quality throughout our network, delivering the highest standards and providing world-class products and services that improve the lives of patients with cancerLearn more